Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss. | Canada Hyperbarics Skip to main content
Retrospective Study European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - 2007

Hyperbaric oxygen and steroid therapy for idiopathic sudden sensorineural hearing loss.

Fujimura T, Suzuki H, Shiomori T, Udaka T, Mori T — European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - , 2007

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers conducted a retrospective analysis comparing hyperbaric oxygen (HBO) plus steroid therapy to steroid therapy alone for idiopathic sudden sensorineural hearing loss (ISSNHL).

What They Found

The recovery rate was significantly higher in the HBO plus steroid group (59.7%) compared to the steroid-only group (39.7%; P < 0.05). For patients with initial hearing levels of ≥80 dB, the HBO group also showed a significantly higher hearing improvement rate (51.1% vs. 27.1%; P < 0.05).

What This Means for Canadian Patients

Canadian patients experiencing sudden sensorineural hearing loss, particularly severe cases, might benefit more from a combination of hyperbaric oxygen and steroid therapy than steroids alone. This combined approach could lead to better hearing recovery outcomes for those affected by this condition.

Canadian Relevance

This study has no direct Canadian connection as it was conducted in a tertiary care academic medical center outside of Canada.

Study Limitations

As a retrospective study, this research is limited by its reliance on existing medical records and potential for selection bias.

Was this summary helpful?

Study Details

Study Type Retrospective Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 17340130
Year Published 2007
Journal European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology -
MeSH Terms Adolescent; Adult; Aged; Aged, 80 and over; Audiometry; Child; Dexamethasone; Dose-Response Relationship, Drug; Female; Glucocorticoids; Hearing; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hydrocortisone

Cite This Study

Share

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.